Assertion: tetanus | /r/MadeOf | vaccine
Facets:
value: at six months old
type: TEMPORAL
value: at four
type: TEMPORAL
value: at two
type: TEMPORAL
value: within the previous 10 years
type: TEMPORAL
Source sentences:
text: The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends administration of a tetanus containing vaccine (DTaP) at two, four, and six months old; between 15 and 18 months old; and between four and six years old.
text: Infanrix vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Infanrix vaccine; The tip caps of prefilled Infanrix syringes contain latex and may cause an allergic reaction in persons sensitive to latex.
text: DAPTACEL vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering DAPTACEL vaccine.
text: Pediarix vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; The tip caps of prefilled Pediarix syringes contain latex and may cause an allergic reaction in persons sensitive to latex; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Pediarix vaccine.
text: ; Persistent crying lasting 3 hours or more within 48 hours of a previous pertussis vaccination; Convulsions with or without fever, occurring within 3 days of a previous pertussis vaccination; Serious allergic reaction to a previous pertussis vaccination; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; Children with a progressive neurologic disorder (such as infantile spasms, uncontrolled epilepsy, or progressive encephalopathy); Severe allergic reaction to any component of Kinrix, including neomycin and polymyxin B (antibiotics); The tip caps of prefilled Kinrix syringes contain latex and may cause an allergic reaction in persons sensitive to latex; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Kinrix vaccine.
text: Serious allergic reaction following administration of a pertussis, tetanus, diphtheria, or polio containing vaccine or any ingredient of Quadracel vaccine; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; Children with a progressive neurologic disorder (such as infantile spasms, uncontrolled epilepsy, or progressive encephalopathy); Seizures within 3 days of a previous pertussis vaccination; Temperature of 105 F. or higher within 48 hours of a previous pertussis vaccination, not attributable to another identifiable cause; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Quadracel vaccine.
text: Pentacel vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Pentacel vaccine.
text: : Temperature of 105 F. or higher within 48 hours of a previous pertussis vaccination, not attributable to another identifiable cause; Collapse or shock-like state (hypotonic-hyporesponsive episodes) within 48 hours of a previous pertussis vaccination; Persistent crying lasting 3 hours or more within 48 hours of a previous pertussis vaccination; Convulsions with or without fever, occurring within 3 days of a previous pertussis vaccination; Serious allergic reaction to a previous dose of VAXELIS, any ingredient found in VAXELIS, or any other tetanus toxoid, diphtheria toxoid, pertussis-containing vaccine, hepatitis B vaccine, inactivated poliovirus vaccine, or H. influenzae type b vaccine; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; Children with a progressive neurologic disorder (such as infantile spasms, uncontrolled epilepsy, or progressive encephalopathy); If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering VAXELIS vaccine; Apnea following intramuscular vaccination has been observed in some infants born prematurely.
text: Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Diphtheria and Tetanus Toxoid Absorbed vaccine; Apnea following intramuscular vaccination has been observed in some infants born prematurely.
text: See Sanofi Pasteur product insert for complete list): Moderate or severe acute illness (with or without fever) until the illness resolves; Serious allergic or hypersensitivity reaction to a previous shot; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; In adolescents, a progressive neurologic disorder, including progressive encephalopathy or uncontrolled epilepsy (convulsions); In adults, an unstable neurologic condition , such as cerebrovascular events and acute encephalopathic conditions; Severe allergic reaction to any component of Adacel; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Adacel vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive Adacel more frequently than every 10 years; The tip caps of prefilled Adacel syringes contain latex and may cause an allergic reaction in persons sensitive to latex.
text: Serious allergic or hypersensitivity reaction to a previous shot; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; In adolescents and adults, a progressive neurologic disorder, including progressive encephalopathy or uncontrolled epilepsy (convulsions); If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Boostrix vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive Boostrix more frequently than every 10 years; The tip caps of prefilled Boostrix syringes contain latex and may cause an allergic reaction in persons sensitive to latex.
text: Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering TDVAX vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive TDVAX more frequently than every 10 years.
text: Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering TENIVAC vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive TDVAX more frequently than every 10 years; The tip caps of prefilled TENIVAC syringes contain latex and may cause an allergic reaction in persons sensitive to latex; Administering TENIVAC vaccine more frequently than prescribed may result in an increased incidence and severity of adverse reactions.
text: following a previous dose of a tetanus containing vaccine.
text: The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends administration of a tetanus containing vaccine (DTaP) at two, four, and six months old; between 15 and 18 months old; and between four and six years old.
text: Infanrix vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Infanrix vaccine; The tip caps of prefilled Infanrix syringes contain latex and may cause an allergic reaction in persons sensitive to latex.
text: DAPTACEL vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering DAPTACEL vaccine.
text: Pediarix vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; The tip caps of prefilled Pediarix syringes contain latex and may cause an allergic reaction in persons sensitive to latex; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Pediarix vaccine.
text: ; Persistent crying lasting 3 hours or more within 48 hours of a previous pertussis vaccination; Convulsions with or without fever, occurring within 3 days of a previous pertussis vaccination; Serious allergic reaction to a previous pertussis vaccination; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; Children with a progressive neurologic disorder (such as infantile spasms, uncontrolled epilepsy, or progressive encephalopathy); Severe allergic reaction to any component of Kinrix, including neomycin and polymyxin B (antibiotics); The tip caps of prefilled Kinrix syringes contain latex and may cause an allergic reaction in persons sensitive to latex; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Kinrix vaccine.
text: Serious allergic reaction following administration of a pertussis, tetanus, diphtheria, or polio containing vaccine or any ingredient of Quadracel vaccine; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; Children with a progressive neurologic disorder (such as infantile spasms, uncontrolled epilepsy, or progressive encephalopathy); Seizures within 3 days of a previous pertussis vaccination; Temperature of 105 F. or higher within 48 hours of a previous pertussis vaccination, not attributable to another identifiable cause; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Quadracel vaccine.
text: Pentacel vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Pentacel vaccine.
text: : Temperature of 105 F. or higher within 48 hours of a previous pertussis vaccination, not attributable to another identifiable cause; Collapse or shock-like state (hypotonic-hyporesponsive episodes) within 48 hours of a previous pertussis vaccination; Persistent crying lasting 3 hours or more within 48 hours of a previous pertussis vaccination; Convulsions with or without fever, occurring within 3 days of a previous pertussis vaccination; Serious allergic reaction to a previous dose of VAXELIS, any ingredient found in VAXELIS, or any other tetanus toxoid, diphtheria toxoid, pertussis-containing vaccine, hepatitis B vaccine, inactivated poliovirus vaccine, or H. influenzae type b vaccine; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; Children with a progressive neurologic disorder (such as infantile spasms, uncontrolled epilepsy, or progressive encephalopathy); If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering VAXELIS vaccine; Apnea following intramuscular vaccination has been observed in some infants born prematurely.
text: Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Diphtheria and Tetanus Toxoid Absorbed vaccine; Apnea following intramuscular vaccination has been observed in some infants born prematurely.
text: See Sanofi Pasteur product insert for complete list): Moderate or severe acute illness (with or without fever) until the illness resolves; Serious allergic or hypersensitivity reaction to a previous shot; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; In adolescents, a progressive neurologic disorder, including progressive encephalopathy or uncontrolled epilepsy (convulsions); In adults, an unstable neurologic condition , such as cerebrovascular events and acute encephalopathic conditions; Severe allergic reaction to any component of Adacel; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Adacel vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive Adacel more frequently than every 10 years; The tip caps of prefilled Adacel syringes contain latex and may cause an allergic reaction in persons sensitive to latex.
text: Serious allergic or hypersensitivity reaction to a previous shot; Encephalopathy (coma, decreased level of consciousness, prolonged convulsions) within 7 days of a previous pertussis vaccination not attributable to another identifiable cause; In adolescents and adults, a progressive neurologic disorder, including progressive encephalopathy or uncontrolled epilepsy (convulsions); If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering Boostrix vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive Boostrix more frequently than every 10 years; The tip caps of prefilled Boostrix syringes contain latex and may cause an allergic reaction in persons sensitive to latex.
text: Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering TDVAX vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive TDVAX more frequently than every 10 years.
text: Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine; If Guillain-Barré syndrome (GBS ) occurred within 6 weeks of receiving a tetanus containing vaccine, careful assessment of the possible risks and potential benefits should be completed prior to considering TENIVAC vaccine; Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive TDVAX more frequently than every 10 years; The tip caps of prefilled TENIVAC syringes contain latex and may cause an allergic reaction in persons sensitive to latex; Administering TENIVAC vaccine more frequently than prescribed may result in an increased incidence and severity of adverse reactions.
text: The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends administration of a tetanus containing vaccine (DTaP) at two, four, and six months old; between 15 and 18 months old; and between four and six years old.
text: Note: Tdap can be administered regardless of the interval between the last tetanus or diphtheria toxoid containing vaccine.
text: How effective is tetanus containing vaccine?
text: It takes days after getting a tetanus containing vaccine for antibody levels against the tetanus bacteria toxins to rise in the blood, and by then symptoms of tetanus infection may have already begun to appear.8
text: In 2016, the CDC reported that 58 percent of adults 65 years and older, 64.2 percent of adults 50 to 64 years, 62.8 percent of adults 19 to 49, and 62.2 percent of adults 19 and younger had received a tetanus containing vaccine within the previous 10 years.
text: Despite the availability of highly effective tetanus toxoid–containing vaccines, tetanus continues to have a substantial health impact in the world.
text: There are also serious adverse effects associated with tetanus containing vaccines (DT, Td, DTaP, Tdap), including “redness, swelling and pain at the injection site; headache; fatigue, sore and swollen joints; muscle weakness; fever; chills; nausea; shock; neuropathy; convulsions; encephalopathy; paralysis; Guillain-Barre Syndrome (GBS); death.”3